200
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

NAMPT/SIRT1 Expression Levels in White Blood Cells Differentiate the Different Rheumatoid Arthritis Subsets: An Inspiration from Traditional Chinese Medicine

, , , , ORCID Icon, , & ORCID Icon show all
Pages 4271-4285 | Received 20 Jul 2023, Accepted 20 Sep 2023, Published online: 26 Sep 2023

References

  • Sharma J, Bhar S, Devi CS. A review on interleukins: the key manipulators in rheumatoid arthritis. Mod Rheumatol. 2017;27(5):723–746. doi:10.1080/14397595.2016.1266071
  • Alam J, Jantan I, Bukhari SNA. Rheumatoid arthritis: recent advances on its etiology, role of cytokines and pharmacotherapy. Biomed Pharmacother. 2017;92:615–633. doi:10.1016/j.biopha.2017.05.055
  • Shiozawa S, Tsumiyama K, Yoshida K, Hashiramoto A. Pathogenesis of joint destruction in rheumatoid arthritis. Arch Immunol Ther Exp. 2011;59(2):89–95. doi:10.1007/s00005-011-0116-3
  • Bergantini L, d’Alessandro M, Cameli P, et al. Effects of rituximab therapy on B cell differentiation and depletion. Clin Rheumatol. 2020;39(5):1415. doi:10.1007/s10067-020-04996-7
  • Yang P, Qian FY, Zhang MF, et al. Th17 cell pathogenicity and plasticity in rheumatoid arthritis. J Leukoc Biol. 2019;106(6):1233–1240. doi:10.1002/JLB.4RU0619-197R
  • Sun L, Yang X, Yuan Z, Wang H. Metabolic reprogramming in immune response and tissue inflammation. Arterioscler Thromb Vasc Biol. 2020;40(9):1990–2001. doi:10.1161/ATVBAHA.120.314037
  • Wyngene LV, Vandewalle J, Libert C. Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last? EMBO Mol Med. 2018;10(8):e8712. doi:10.15252/emmm.201708712
  • García-Chagollán M, Hernández-Martínez SE, Rojas-Romero AE, et al. Metabolic syndrome in rheumatoid arthritis patients: relationship among its clinical components. J Clin Lab Anal. 2021;35(3):e23666. doi:10.1002/jcla.23666
  • Venetsanopoulou AI, Pelechas E, Voulgari PV, Drosos AA. The lipid paradox in rheumatoid arthritis: the dark horse of the augmented cardiovascular risk. Rheumatol Int. 2020;40(8):1181–1191. doi:10.1007/s00296-020-04616-2
  • Jiang P, Li H, Li X. Diabetes mellitus risk factors in rheumatoid arthritis: a systematic review and meta-analysis. Clin Exp Rheumatol. 2015;33(1):115–121.
  • Zheng HX, Yang Z. Basic Theory of Traditional Chinese Medicine. Beijing: China Press of Traditional Chinese Medicine; 2021:19–26.
  • Chen J, Cheng HB. Fundamentals of Traditional Chinese Medicine. Beijing: China Press of Traditional Chinese Medicine; 2021:106–157.
  • Rheumatology Branch of Chinese Association of Traditional Chinese Medicine. The guidelines for diagnosis and theory of rheumatoid arthritis combing diseases and syndromes. J Tradit Chin Med. 2018;59:1794–1798.
  • Li S, Lu AP, Wang YY, Li YD. Suppressive effects of a Chinese herbal medicine Qing-Luo-Yin extract on the angiogenesis of collagen-induced arthritis in rats. Am J Chin Med. 2003;31(5):713–720. doi:10.1142/S0192415X03001430
  • Zhang E. Bi Syndrome (Arthralgia Syndrome). J Tradit Chin Med. 2010;30(2):145–152.
  • Al-Khami AA, Rodriguez PC, Ochoa AC. Energy metabolic pathways control the fate and function of myeloid immune cells. J Leukoc Biol. 2017;102(2):369–380. doi:10.1189/jlb.1VMR1216-535R
  • Lei M, Tao MQ, Wu YJ, et al. Metabolic enzyme triosephosphate isomerase 1 and nicotinamide phosphoribosyltransferase, two independent inflammatory indicators in rheumatoid arthritis: evidences from collagen-induced arthritis and clinical samples. Front Immunol. 2022;12:795626. doi:10.3389/fimmu.2021.795626
  • Imai S. Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases. Curr Pharm Des. 2009;15(1):20–28. doi:10.2174/138161209787185814
  • Xie J, Zhang X, Zhang L. Negative regulation of inflammation by SIRT1. Pharmacol Res. 2013;67(1):60–67. doi:10.1016/j.phrs.2012.10.010
  • Wu YJ, Fang WJ, Pan S, et al. Regulation of Sirt1 on energy metabolism and immune response in rheumatoid arthritis. Int Immunopharmacol. 2021;101(Pt A):108175. doi:10.1016/j.intimp.2021.108175
  • Yu LJ, Ji CL, Wang Y, et al. Changes within liver accounts for fatty acids decrease in the blood of rats with adjuvant-induced arthritis. Eur J Lipid Sci Tech. 2023;125(4):2200142.
  • Yang Z, Matteson EL, Goronzy JJ, Weyand CM. T-cell metabolism in autoimmune disease. Arthritis Res Ther. 2015;17(1):29. doi:10.1186/s13075-015-0542-4
  • Kondratyeva LV, Popkova TV, Nasonov E. Insulin resistance in rheumatoid arthritis: relationship to lipid metabolism disorders and metabolic syndrome. Rheumatol Sci Pract. 2019;57(3):280–283. doi:10.14412/1995-4484-2019-280-283
  • Inamo J, Kochi Y, Takeuchi T. Is type 2 diabetes mellitus an inverse risk factor for the development of rheumatoid arthritis? J Hum Genet. 2021;66(2):219–223. doi:10.1038/s10038-020-00837-2
  • Vandewalle J, Libert C. Sepsis: a failing starvation response. Trends Endocrinol Metab. 2022;33(4):292–304. doi:10.1016/j.tem.2022.01.006
  • Rajbhandary R, Khezri A, Panush RS. Rheumatoid cachexia: what is it and why is it important? J Rheumatol. 2011;38(3):406–408. doi:10.3899/jrheum.101036
  • Weyand CM, Goronzy JJ. Immunometabolism in the development of rheumatoid arthritis. Immunol Rev. 2020;294(1):177–187. doi:10.1111/imr.12838
  • Franco-Trepat E, Alonso-Pérez A, Guillán-Fresco M, et al. Visfatin as a therapeutic target for rheumatoid arthritis. Expert Opin Ther Targets. 2019;23(7):607–618. doi:10.1080/14728222.2019.1617274
  • Rasha F, Mims BM, Castro-Piedras I, et al. The versatility of Sirtuin-1 in endocrinology and immunology. Front Cell Dev Biol. 2020;8:589016. doi:10.3389/fcell.2020.589016
  • Wang QH, Li Y, Dou DY, et al. Nicotinamide mononucleotide-elicited NAMPT signaling activation aggravated adjuvant-induced arthritis in rats by affecting peripheral immune cells differentiation. Int Immunopharmacol. 2021;98:107856. doi:10.1016/j.intimp.2021.107856
  • Perez-Sanchez C, Escudero-Contreras A, Cerdó T, et al. Preclinical characterization of pharmacologic NAD+ boosting as a promising therapeutic approach in rheumatoid arthritis. Arthritis Rheumatol. 2023. doi:10.1002/art.42528
  • Wang DD, He CY, Wu YJ, et al. AMPK/SIRT1 deficiency drives adjuvant-induced arthritis in rats by promoting glycolysis-mediated monocytes inflammatory polarization. J Inflamm Res. 2022;15:4663–4675. doi:10.2147/JIR.S378090
  • Jiang TT, Ji CL, Yu LJ, et al. Resveratrol-induced SIRT1 activation inhibits glycolysis-fueled angiogenesis under rheumatoid arthritis conditions independent of HIF-1α. Inflamm Res. 2023;72(5):1021–1035. doi:10.1007/s00011-023-01728-w
  • Niederer F, Ospelt C, Brentano F, et al. SIRT1 overexpression in the rheumatoid arthritis synovium contributes to proinflammatory cytokine production and apoptosis resistance. Ann Rheum Dis. 2011;70(10):1866–1873. doi:10.1136/ard.2010.148957
  • Yoon MJ, Yoshida M, Johnson S, et al. SIRT1-mediated eNAMPT secretion from adipose tissue regulates hypothalamic NAD+ and function in mice. Cell Metab. 2015;21(5):706–717. doi:10.1016/j.cmet.2015.04.002
  • Zhou Y, Deng HW, Shen H. Circulating monocytes: an appropriate model for bone-related study. Osteoporos Int. 2015;26(11):2561–2572. doi:10.1007/s00198-015-3250-7
  • Park SY, Lee SW, Kim HY, et al. SIRT1 inhibits differentiation of monocytes to macrophages: amelioration of synovial inflammation in rheumatoid arthritis. J Mol Med. 2016;94(8):921–931. doi:10.1007/s00109-016-1402-7